Okay, let's tackle this question about malignant hyperthermia related to inhalational halogenated anesthetics. First, I need to recall what malignant hyperthermia is. It's a life-threatening condition triggered by certain anesthetics, leading to a rapid increase in body temperature, muscle rigidity, and metabolic acidosis. The core concept here is the interaction between specific anesthetics and a genetic predisposition in the patient.

The correct answer should be the anesthetic known to trigger malignant hyperthermia. From what I remember, halogenated agents like halothane, sevoflurane, and isoflurane are the usual culprits. Succinylcholine, a depolarizing muscle relaxant, is also a trigger, but the question specifies inhalational halogenated anesthetics. So looking at the options, I need to identify which one is among these agents.

Now, the options aren't listed, but common distractors might include propofol, which isn't halogenated and doesn't cause malignant hyperthermia. Desflurane and sevoflurane are halogenated and can trigger it. Nitrous oxide is an inhalational anesthetic but not halogenated and doesn't cause this condition. So if the options include these, the correct answer would be one of the halogenated agents like sevoflurane or desflurane.

Wait, the question is from KDT 6th edition and Lippincott's 3rd pharmacology, so I should cross-reference there. Classic triggers are halothane, enflurane, isoflurane, sevoflurane, and desflurane. Succinylcholine is another trigger but is a muscle relaxant, not an inhalational agent. So if the options include succinylcholine, that's a distractor. The correct answer is likely one of the halogenated anesthetics. The clinical pearl here is that malignant hyperthermia is a genetic disorder related to a mutation in the ryanodine receptor, leading to uncontrolled calcium release in muscle cells. Treatment is with dantrolene.

**Core Concept**
Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder triggered by volatile halogenated anesthetics (e.g., halothane, sevoflurane) and succinylcholine, causing uncontrolled calcium release in skeletal muscle. It is linked to mutations in the ryanodine receptor (RYR1) gene.

**Why the Correct Answer is Right**
Halogenated inhalational anesthetics like **sevoflurane** and **desflurane** are classic MH triggers. They activate mutated RYR1 receptors, leading to excessive cytosolic calcium, sustained muscle contraction, metabolic acidosis, and hyperthermia. Diagnosis relies on clinical suspicion and confirmed via caffeine-halothane contracture test (CHCT).

**Why Each Wrong Option is Incorrect**
**Option A:** *Nitrous oxide* is non-halogenated and does not trigger MH.
**Option B:** *Propofol*, a non-halogenated intravenous anesthetic, is MH-safe and used in MH management.
**Option C:** *Ketamine* is not associated

✓ Correct Answer: D. Genetic defect in calcium channel at sarcoplasmic reticulum of the skeletal muscle